FindTrial
Sign In

Comparing pharmacotherapy with pharmacotherapy and relaxation in migraine

Randomised control Trial to assess the quality of life and disability in migraine and to compare enhanced therapy with standard pharmacotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/12/022538
Enrollment
330
Registered
2019-12-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Control Intervention1: Relaxation therapy: Comparing the effect of relaxation therapy+ standard pharmacotherapy with standard pharmacotherapy alone

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed migraine cases

Exclusion criteria

Exclusion criteria: Not willing to participate Already on treatment

Design outcomes

Primary

MeasureTime frame
Assessment of health related quality of life in migraine using Migraine specific quality of life score, disability using Migraine disability score and severity using HIT 6 score before and after treatment Comparing effect of Standard pharmacotherapy and enhanced pharmacotherapy(standard plus relaxation therapy) Timepoint: The participants will be reassessed 8 weeks after starting treatment—

Secondary

MeasureTime frame
Overall impact of migraine on health related quality of life Assessing the change in quality of life after treatment in migraineTimepoint: This will be done at the time of enrolment and later followed up after 8 weeks—

Countries

India

Contacts

Public ContactDr Rajveer Singh

PGIMER, Chandigarh

sagar77khera@gmail.com9416088438

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026